DocJohn
10-31-2007, 01:40 AM
(From Yahoo) HealthDay - TUESDAY, Oct. 30 (HealthDay News) -- An experimental drug calledaxitinib shows promise for treating people with what's known ascytokine-refractory metastatic kidney cancer -- a group of patients whotypically have a poor response to drug treatment.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20071031/hl_hsn/newdrugpromisingagainsttoughtotreatkidneycancer)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20071031/hl_hsn/newdrugpromisingagainsttoughtotreatkidneycancer)